|
WO2019210034A1
|
|
Compositions and methods for evaluating potency of listeria-based immunotherapeutics
|
|
CN112074737A
|
|
Compositions and methods for evaluating listeria strains for attenuation and infectivity
|
|
WO2019157098A1
|
|
Compositions comprising a recombinant listeria strain and an anti-ccr8 antibody and methods of use
|
|
EP3707152A2
|
|
Immunogenic heteroclitic peptides from cancer-associated proteins and methods of use thereof
|
|
SG11202002157TA
|
|
Compositions and methods for lyophilization of bacteria or listeria strains
|
|
WO2019006401A2
|
|
Listeria-based immunogenic compositions comprising heteroclitic wilms tumor protein antigens and methods of use thereof
|
|
WO2018170313A1
|
|
Methods and compositions for increasing efficacy of vaccines
|
|
WO2018129306A1
|
|
Recombinant listeria vaccine strains and methods of using the same in cancer immunotherapy
|
|
WO2018102585A1
|
|
Personalized immunotherapy in combination with immunotherapy targeting recurrent cancer mutations
|
|
SG11201901979SA
|
|
Immunogenic compositions targeting recurrent cancer mutations and methods of use thereof
|
|
US2020061167A1
|
|
Combination of listeria-based vaccine with anti-ctla-4 or anti-cd137 antibodies
|
|
AU2017293400A1
|
|
Listeria-based immunogenic compositions comprising Wilms tumor protein antigens and methods of use thereof
|
|
MX2018009225A
|
|
Personalized delivery vector-based immunotherapy and uses thereof.
|
|
AU2016369580A1
|
|
Listeria-based immunotherapy and methods of use thereof
|
|
WO2017085691A1
|
|
Manufacturing device and method of an immunotherapeutic formulation comprising a recombinant listeria strain
|
|
CN108368513A
|
|
Recombinant listeria bacterium vaccine strains and its method for immunotherapy for cancer
|
|
MX2018003352A
|
|
Recombinant listeria vaccine strains and methods of using the same in cancer immunotherapy.
|
|
US2018305702A1
|
|
Listeria-Based Immunogenic Compositions And Methods Of Use Thereof in Cancer Prevention And Treatment
|
|
EP3350337A1
|
|
Manufacturing method of an immunotherapeutic formulation comprising a recombinant listeria strain
|
|
JP2016189788A
|
|
Usage of recombinant listeria strains in manufacturing medical drug for delaying onset of brain tumor or mammary gland tumor
|
